TSL Express Daily News

The Secured Lender

Screenshot 2025-10-30 at 12.06.01 PM 

SFNet's The 81st Annual Convention Issue
 

Intro content. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Curabitur iaculis sapien sagittis, accumsan magna ut, blandit massa. Quisque vehicula leo lorem, a tincidunt eros tempor nec. In quis lacus vitae risus egestas tincidunt. Phasellus nulla risus, sodales in purus non, euismod ultricies elit. Vestibulum mattis dolor non sem euismod interdum.

#3 -_ 1 (1)

December 1, 2025

Source: Cahill

Cahill represented the lead arrangers in connection with an amendment to Halozyme Therapeutics, Inc.'s credit agreement to extend the maturity and increase the revolving credit facility by $175 million to $750 million.

Halozyme Therapeutics, Inc. is a biopharma technology platform company that provides innovative and disruptive solutions with the goal of improving patient experience and outcomes.